Brief

"On 12/02/2025, the Therapeutic Goods Administration (TGA) issued an update regarding Product Information safety updates - February 2025. This update reports on recent changes to the Product Information of several medicines, including Neotigason and Spikevax Xbb, which have been updated to include new contraindications, warnings, and precautions. The TGA has also published a Medicines Safety Update article detailing recent safety-related updates."

This content is restricted.

Highlights content goes here...

This content is restricted.

Therapeutic Goods Administration (TGA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies